Sp913
INTERDISCIPLINARY MODELS OF NUTRITION AND OBESITY CARE: INCORPORATING DIETITIANS AND COLLABORATING SPECIALISTS INTO GASTROENTEROLOGY TRAINING AND PRACTICE
Date
May 8, 2023
Explore related products in the following collection:
Society: AGA
This session, designed for the fellows, clinician educator and program director focuses on designing and delivering curricula for GI fellows on the topics of nutrition, including the obesity epidemic. After a review of the current state and vision or the future, three clinician educators and nutrition experts will highlight resources and approaches to address this vital topics that most training programs struggle to cover. Unique to this session will be the collaboration with a dietician to discuss an approach for interprofessional training in GI using, a core component of ACGME program requirements.
This session, designed for the fellows, clinician educator and program director focuses on designing and delivering curricula for GI fellows on the topics of nutrition, including the obesity epidemic. After a review of the current state and vision or the future, three clinician educators and nutrition experts will highlight resources and approaches to address this vital topics that most training programs struggle to cover. Unique to this session will be the collaboration with a dietician to discuss an approach for interprofessional training in GI using, a core component of ACGME program requirements.
Presenter
Weill Cornell Medical College
Tracks
Related Products
PANEL DISCUSSION
This session, designed for the fellows, clinician educator and program director focuses on designing and delivering curricula for GI fellows on the topics of nutrition, including the obesity epidemic…
PLACEHOLDER
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
ENCAPSULATED MICROBIOTA TRANSPLANT THERAPY IMPROVES PARTIAL MAYO SCORES IN ULCERATIVE COLITIS AND INDUCES RAPID ENGRAFTMENT COMPARED TO PLACEBO CONTROL
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
INTRODUCTION
SOCIETY: AGA
